Literature DB >> 21703178

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

Matthew J Armstrong1, Diarmaid D Houlihan, Louise Bentham, Jean C Shaw, Robert Cramb, Simon Olliff, Paramjit S Gill, James M Neuberger, Richard J Lilford, Philip N Newsome.   

Abstract

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is a common cause of abnormal LFTs in primary care, but there are no data defining its contribution nor reporting the range of NAFLD severity in this setting. This study seeks to calculate the range of disease severity of NAFLD in a primary care setting.
METHODS: Adult patients with incidental abnormal LFTs, in the absence of a previous history, or current symptoms/signs of liver disease were prospectively recruited from eight primary care practices in Birmingham. NAFLD was diagnosed as fatty liver on ultrasound, negative serological liver aetiology screen, and alcohol consumption ≤30 and ≤20 g/day in males and females, respectively. The NAFLD Fibrosis Score (NFS) was calculated to determine the presence or absence of advanced liver fibrosis in subjects identified with NAFLD.
RESULTS: Data from 1118 adult patients were analysed. The cause of abnormal LFTs was identified in 55% (614/1118) of subjects, with NAFLD (26.4%; 295/1118) and alcohol excess (25.3%; 282/1118) accounting for the majority. A high NFS (>0.676) suggesting the presence of advanced liver fibrosis was found in 7.6% of NAFLD subjects, whereas 57.2% of NAFLD patients had a low NFS (<-1.455) allowing advanced fibrosis to be confidently excluded.
CONCLUSIONS: NAFLD is the commonest cause of incidental LFT abnormalities in primary care (26.4%), of whom 7.6% have advanced fibrosis as calculated by the NFS. This study is the first of its kind to highlight the burden of NAFLD in primary care and provide data on disease severity in this setting.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21703178     DOI: 10.1016/j.jhep.2011.03.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  99 in total

1.  Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.

Authors:  Robert J Pattison; James Phillip Esteban; Tomoki Sempokuya; Jakrin Kewcharoen; Sumodh Kalathil; Scott K Kuwada
Journal:  Hawaii J Health Soc Welf       Date:  2020-06-01

2.  Non-alcoholic liver disease in an HGV driver.

Authors:  Ibrahim Al-Bakir; Senan Devendra
Journal:  London J Prim Care (Abingdon)       Date:  2015

Review 3.  Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

4.  Caution in Using Non-Invasive Scoring Systems in NAFLD Beyond Highly Selected Study Populations.

Authors:  M J Armstrong; D Schmidt-Martin; I A Rowe; P N Newsome
Journal:  Am J Gastroenterol       Date:  2017-04       Impact factor: 10.864

5.  Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-(13)C]pyruvate.

Authors:  Sonal Josan; Kelvin Billingsley; Juan Orduna; Jae Mo Park; Richard Luong; Liqing Yu; Ralph Hurd; Adolf Pfefferbaum; Daniel Spielman; Dirk Mayer
Journal:  NMR Biomed       Date:  2015-10-16       Impact factor: 4.044

Review 6.  Epidemiology of fatty liver: an update.

Authors:  Giorgio Bedogni; Valerio Nobili; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

7.  Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

Authors:  Srinevas K Reddy; Colleen Reilly; Min Zhan; Ayse L Mindikoglu; Yixing Jiang; Barton F Lane; H Richard Alexander; William J Culpepper; Samer S El-Kamary
Journal:  Med Oncol       Date:  2014-05-06       Impact factor: 3.064

Review 8.  The Effects of Physical Exercise on Fatty Liver Disease.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Allan Tsung; Hai Huang
Journal:  Gene Expr       Date:  2017-12-06

9.  Liver reserve function assessment by acoustic radiation force impulse imaging.

Authors:  Xiao-Lan Sun; Li-Wei Liang; Hui Cao; Qiong Men; Ke-Zhu Hou; Zhen Chen; Ya-E Zhao
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

10.  Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.

Authors:  Srinevas K Reddy; Min Zhan; H Richard Alexander; Samer S El-Kamary
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.